SCHEMBL23749489

SCHEMBL23749489

COc1ccn(-c2ccc(F)cc2)c(=O)c1C(=O)Nc1ccc(Oc2ccnc3ccc4c(c23)OCCO4)cc1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
RET P07949 2/20 0.57
MET P08581 12/20 0.57
AXL P30530 6/20 0.52
MST1R Q04912 5/20 0.52
TYRO3 Q06418 3/20 0.52
AURKA O14965 1/20 0.47
KDR P35968 3/20 0.45
LCK P06239 2/20 0.45
TEK Q02763 1/20 0.45
MERTK Q12866 2/20 0.45
PDGFRA P16234 2/20 0.45
PLK4 O00444 1/20 0.45
ABL1 P00519 1/20 0.45
NTRK1 P04629 1/20 0.45
KIT P10721 1/20 0.45
PRKACA P17612 1/20 0.45
FLT3 P36888 1/20 0.45
ABL2 P42684 1/20 0.45
FRK P42685 1/20 0.45
DDR1 Q08345 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23749322 0.93 AXL (0.57) RETMETAXLMST1RTYRO3
SCHEMBL23749298 0.91 MET (0.70) RETMETAXLMST1RTYRO3
SCHEMBL23749488 0.90 MET (0.52) RETMETAXLMST1RTYRO3
SCHEMBL23749519 0.87 AURKA (0.62) RETMETAXLTYRO3AURKA
SCHEMBL23749380 0.84 MET (0.69) RETMETAXLMST1RTYRO3
SCHEMBL23749551 0.83 MST1R (0.53) RETMETAXLMST1RTYRO3
SCHEMBL23749422 0.82 MET (0.76) RETMETAXLMST1RTYRO3
SCHEMBL23749554 0.80 MET (0.65) RETMETAXLTYRO3MERTK
SCHEMBL23749440 0.80 RET (0.59) RETMETAXLMST1RTYRO3
SCHEMBL23749503 0.79 MET (0.70) RETMETAXLMST1RTYRO3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12202835-B2 Substituted aromatic ring-linked dioxinoquinazolines and dioxinoquinolines as kinase inhibitors BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED (CN) 2025-01-21 US disclosed
US-20220002308-A1 AROMATIC RING-LINKED DIOXINO-QUINAZOLINE OR DIOXINO-QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED (CN) 2022-01-06 US disclosed
US-20220002308-A1 AROMATIC RING-LINKED DIOXINO-QUINAZOLINE OR DIOXINO-QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF BEIJING SCITECH-MQ PHARMACEUTICALS LIMITED (CN) 2022-01-06 US disclosed
EP-3865487-A1 AROMATIC RING-LINKED DIOXANE-QUINAZOLINE OR -QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF Beijing Scitech-MQ Pharmaceuticals Limited (CN) 2021-08-18 EP disclosed
EP-3865487-A1 AROMATIC RING-LINKED DIOXANE-QUINAZOLINE OR -QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF Beijing Scitech-MQ Pharmaceuticals Limited (CN) 2021-08-18 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20220002308-A1 AROMATIC RING-LINKED DIOXINO-QUINAZOLINE OR DIOXINO-QUINOLINE COMPOUNDS, COMPOSITIONS AND USE THEREOF MERTK, AXL, TYRO3 RET 4/4885MET 14/4885AXL 2/4885
US-12202835-B2 Substituted aromatic ring-linked dioxinoquinazolines and dioxinoquinolines as kinase inhibitors MERTK, AXL, TYRO3 RET 4/4885MET 12/4885AXL 2/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.